74 studies found for:    Open Studies | "Warfarin"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist Clinic
Condition: Intentional Warfarin Sodium Overdose
Intervention: Other: patient education
2 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
3 Recruiting Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Conditions: Anti-coagulation Therapy;   DVT;   Pulmonary Embolism;   Joint Surgery Multiple;   Atrial Fibrillation;   Prosthetic Replacement of Mitral Valve
Intervention: Device: Warfarin GenoSTAT Test
4 Unknown  Predictors of Anticoagulation Control on Warfarin Therapy
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:
5 Unknown  Randomized Trial of Interventions to Improve Warfarin Adherence
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Dilated Cardiomyopathies
Interventions: Behavioral: Financial Incentive  and Med-eMonitor;   Device: 2Med-eMonitor
6 Recruiting The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
Conditions: Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis;   Deep Venous Thrombosis;   Thromboembolism;   DVT
Intervention: Drug: Warfarin
7 Recruiting Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
Conditions: Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis
Intervention: Drug: Warfarin
8 Not yet recruiting Pharmacogenetics of Warfarin in Caribbean Hispanics
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions: Genetic: Genotype-guided;   Other: Standard-of-Care
9 Recruiting Use of Warfarin After the First Trimester in Pregnant Women With APS
Conditions: Recurrent Miscarriage;   Antiphospholipid Syndrome
Interventions: Drug: Enoxaparin;   Drug: Warfarin
10 Recruiting Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Disease
Interventions: Other: Genotype-guided warfarin dosing;   Other: Non-genotype guided warfarin dosing
11 Not yet recruiting Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
Conditions: Atrial Fibrillation;   Chronic Kidney Disease
Interventions: Drug: warfarin;   Drug: aspirin
12 Recruiting Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Condition: Atrial Fibrillation
Interventions: Drug: apixaban;   Drug: warfarin
13 Unknown  The Study of Warfarin Maintenance Dose in Chinese Patients
Conditions: Atrial Fibrillation;   Heart Valve Disease;   Pulmonary Artery Embolism
Intervention: Drug: Warfarin
14 Recruiting Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
Conditions: Cirrhosis;   Hypertension;   Venous Thrombosis;   Status; Splenectomy
Interventions: Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin Calcium
15 Recruiting Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
Conditions: Cirrhosis;   Hypertension;   Status;Splenectomy;   Venous Thrombosis
Interventions: Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin  Calcium
16 Unknown  Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Condition: Primary Disease
Interventions: Drug: Dabigatran;   Drug: Warfarin
17 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic;   Drug: Target INR 1.8
18 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration
19 Unknown  The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
Condition: Deep Venous Thromboembolism
Intervention: Drug: warfarin
20 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years